Gynecological neoplasms associated with paraneoplastic hypercalcemia

Area of Science:

• Gynecologic Oncology
• Endocrinology
• Onconephrology

Background:

• Paraneoplastic hypercalcemia is a rare complication of gynecological malignancies, occurring in approximately 5% of cases.
• Early recognition of paraneoplastic hypercalcemia is crucial for timely diagnosis and management of underlying gynecological tumors.
• This condition can serve as an indicator for treatment response and disease recurrence.

Purpose of the Study:

• To review the clinicopathological features of gynecological tumors associated with paraneoplastic hypercalcemia.
• To discuss the differential diagnosis and management strategies for these specific gynecological cancers.
• To highlight the importance of awareness regarding paraneoplastic hypercalcemia in gynecological oncology.

Main Methods:

• Literature review of gynecological malignancies associated with paraneoplastic hypercalcemia.
• Analysis of clinicopathological characteristics of selected tumor types.
• Discussion of diagnostic and therapeutic challenges.

Main Results:

• Small cell carcinoma (hypercalcemic type), ovarian clear cell carcinoma, dysgerminoma, and juvenile granulosa cell tumors are key gynecological malignancies linked to paraneoplastic hypercalcemia.
• Paraneoplastic hypercalcemia can be an early sign, aiding in the detection of these rare gynecological cancers.
• Monitoring calcium levels can assist in evaluating treatment efficacy and identifying recurrence.

Conclusions:

• Awareness of paraneoplastic hypercalcemia in gynecological oncology is vital for prompt diagnosis and effective patient management.
• Understanding the association between hypercalcemia and specific tumors improves prognostic accuracy.
• Integrated management approaches are necessary for addressing both the malignancy and the metabolic complication.